Making Clinical Trials Safer for Human Subjects
- 1 January 2001
- journal article
- research article
- Published by Cambridge University Press (CUP) in American Journal of Law & Medicine
- Vol. 27 (2-3) , 253-282
- https://doi.org/10.1017/s0098858800011503
Abstract
The pace of medical innovation is quickening, pushed by advances in biotechnology and pulled by growing demand for healthcare. Completion of the Human Genome Project has provided a multitude of data for determining genes and their functions, and stimulated the application of information technology and private capital for the development of new individualized drugs, gene therapies, and biomaterials for tissue and organ regeneration. Concurrently, demand for healthcare continues to grow, expanding the market for medical innovations that are proven in clinical trials to be safe and effective.Keywords
This publication has 0 references indexed in Scilit: